Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or California for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to California only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. California (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

City Of Hope National Medical Center (NPI 1750358297)

Field	Value
Entity Type	Organization
Organization	City Of Hope National Medical Center
Address	1500 Duarte Rd
City	Duarte
State	CA
ZIP	91010
Taxonomy	General Acute Care Hospital
NPI Enumerated	March 3, 2006

Payer Source	Total Paid
Medicaid	$175.7M
Medicare	$0

Key Findings

CITY OF HOPE NATIONAL MEDICAL CENTER is effectively a single-payer Medicaid provider: there is no Medicare billing on file while total Medicaid revenue is $175.7M. The facility’s NPI was enumerated on 2006-03-03 (~20 years ago), indicating long-standing participation in public programs despite the absence of Medicare claims.

Revenue is highly concentrated in a small set of outpatient oncology and imaging services: the precomputed top three Medicaid codes — J9271, 77386, and 78815 — together account for 32.3% of this provider’s total Medicaid revenue. Individually those codes are J9271 $21.3M (18.1%), 77386 $8.5M (7.2%), and 78815 $8.2M (6.9%), showing a heavy dependence on high-cost immunotherapy, advanced radiation delivery, and PET/CT imaging.

The code mix points to a comprehensive cancer center operation with high-volume infusion, systemic therapy, and specialty procedures: notable oncology drug codes include J9271 (pembrolizumab), J9299 (nivolumab, $8.1M revenue), J9144 (daratumumab, $6M revenue) and J9358 (fam-trastuzumab deruxtecan, $4.8M revenue). High chemotherapy administration volume is visible in 96413 (37.6K claims, $4.5M revenue), supporting the interpretation of extensive outpatient oncology treatment throughput.

CITY OF HOPE shows particular strength in radiation oncology and advanced imaging: 77386 (complex IMRT) has 6.7K claims and $8.5M revenue, while 78815 (PET/CT) has 5.7K claims and $8.2M revenue and is described as an extreme outlier at the 98th percentile. Additional high-volume diagnostic imaging codes such as 71260 (12K claims, $3.2M revenue) and 74178 (5.8K claims, $3.3M revenue) reinforce a vertically integrated imaging-and-treatment service line.

The provider is a dominant statewide player for multiple high-cost oncology drugs and procedures: examples include J9144 (rank #1 of 9, 100th percentile), J9358 (rank #1 of 3, 100th percentile), J2506 (rank #1 of 16, 100th percentile), Q5107 (rank #1 of 17, 100th percentile), Q5117 (rank #1 of 8, 100th percentile) and 96413 (rank #1 of 319, 100th percentile). These top ranks and 100th-percentile listings indicate the center is a primary hub for these therapies within California.

Operational scale is reflected in very large outpatient and laboratory volumes: G0463 (hospital outpatient clinic visit) shows 93.4K claims ($2.2M revenue), 80053 (CMP) has 92.6K claims ($4.9M revenue), and 85025 (CBC) has 84.7K claims ($1.8M revenue). These high claim counts point to sustained clinic throughput and an on-site lab infrastructure that supports high-frequency oncology monitoring and pre-/post-treatment care.

Average paid-per-claim values emphasize treatment cost intensity: biologic and immune-oncology agents report high avg paid/claim figures such as J9271 $5906 avg paid/claim, J9299 $4091 avg paid/claim, J9144 $4555 avg paid/claim and J9358 $3813 avg paid/claim. The mix of high-cost per-claim biologics plus high-volume chemo administration suggests revenue is driven by both unit price and treatment frequency.

The absence of Medicare billing creates a concentrated payer exposure and a limited national Medicare footprint for comparative measures: contracting, reimbursement negotiation, and revenue risk are therefore heavily tied to Medicaid dynamics in California. For analysts, this pattern signals both concentrated dependence on state Medicaid policy and the need to benchmark performance primarily against in-state peers rather than national Medicare data.

Medicaid: Complete Services Breakdown

Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.

412 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	3,610	$5,910	$21.3M
77386	Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex	6,720	$1,270	$8.5M
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	5,740	$1,420	$8.2M
J9299	Injection, nivolumab, 1 mg	1,980	$4,090	$8.1M
J9144	Injection, daratumumab, 10 mg and hyaluronidase‑fihj	1,320	$4,560	$6M
J9306	Injection, pertuzumab, 1 mg	1,140	$4,480	$5.1M
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	92,590	$50	$4.9M
J9358	Injection, fam-trastuzumab deruxtecan-nxki, 1 mg	1,270	$3,810	$4.8M
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	3,570	$1,260	$4.5M
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	37,640	$120	$4.5M

Showing 1–10 of 412

Medicaid: Competitive Analysis & Benchmarks

How this provider's Medicaid billing volume and revenue compare to other California providers billing the same CPT/HCPCS codes.

Claims Volume vs. California Distribution

City Of Hope National Medical Center — 14 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — California

Full comparison — all codes billed, vs. California median

412 rows

CPT/HCPCS Code	Description	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	Injection, pembrolizumab, 1 mg	4	60	240	$4,460	$3.4M
J9299	Injection, nivolumab, 1 mg	3	20	810	$3,160	$3.1M
38204	The provider manages the search for a suitable donor and acquisition of hematopoietic progenitor cells (HPCs) compatible with the recipient.	1	10	650	$4,610	$3M
J9264	Injection, paclitaxel protein-bound particles, 1 mg	2	10	60	$2,520	$2.9M
77386	Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex	5	20	880	$600	$2.4M
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	8	10	1,000	$790	$1.8M
J9358	Injection, fam-trastuzumab deruxtecan-nxki, 1 mg	1	10	120	$3,650	$1.7M
J9144	Injection, daratumumab, 10 mg and hyaluronidase‑fihj	1	10	220	$4,600	$1.5M
A0429	Ambulance service, basic life support, emergency transport (bls-emergency)	241	390	1,270	$220	$1.5M
J2505	Injection, pegfilgrastim, 6 mg	3	30	220	$2,310	$1.2M

Showing 1–10 of 412

Nearby Providers

Other providers in the same ZIP code as City Of Hope National Medical Center, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
City Of Hope Medical Foundation	CA	Hematology & Oncology Physician	$0	$40.6M
Path Md Inc	CA	Clinical Medical Laboratory	$6.1M	$8.2M
Amrita Krishnan	CA	Hematology (Internal Medicine) Physician	$1.2M	$0
Arya Amini	CA	Radiation Oncology Physician	$412.9K	$0
Phuc Le	CA	Ophthalmology Physician	$322K	$0
Brady Miller	CA	Urology Physician	$318.2K	$0
Thomas Deguzman	CA	Physical Therapist	$305.9K	$0
Sydney Chung	CA	Physician Assistant	$289.7K	$0
Cathie Chung	CA	Medical Oncology Physician	$251.6K	$0
Hyun Kim	CA	Radiation Oncology Physician	$210.4K	$0

City Of Hope National Medical Center — Billing Profile & Reimbursement Data

Sign up for City Of Hope National Medical Center — Billing Profile & Reimbursement Data policy alerts

City Of Hope National Medical Center — Billing Profile & Reimbursement Data

Sign up for City Of Hope National Medical Center — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicaid: Total Revenue Breakdown by CPT/HCPCS Code

Medicaid: Complete Services Breakdown

Medicaid: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References